| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Psychiatry and Radiology, Columbia University College of Physicians and Surgeons, New York; and Division of Brain Imaging, Department of Neuroscience, New York State Psychiatric Institute, New York, New York
Because of its computational simplicity, the graphic method introduced by Logan et al. is frequently used to analyze time–activity curves of reversible radiotracers measured in brain regions with PET. The graphic method uses a nonlinear transformation of data to variables that have an asymptotically linear relationship. Compared with compartmental analysis of untransformed data, the graphic method enables derivation of regional distribution volumes that are free from assumptions about the underlying compartmental configuration. In this article, we describe statistical bias associated with this nonlinear transformation method. Methods: Theoretic analysis, Monte Carlo simulation, and statistical analysis of PET data were used to test the graphic method for bias. Results: Mean zero noise is associated with underestimation of distribution volumes when data are analyzed with graphic analysis, whereas this effect does not occur when the same data are analyzed by nonlinear regression and compartmental analysis. Moreover, this effect depends on the magnitude of the distribution volume, so that the bias is more pronounced in regions with high receptor density than regions with low receptor density or no receptors (region of reference). Conclusion: These results indicate that conventional kinetic analysis of untransformed data is less sensitive to mean zero noise than is graphic analysis of nonlinearly transformed data.
Key Words: PET • kinetic modeling • graphic analysis • noise
Received Dec. 13, 1999; revision accepted May 5, 2000.
For correspondence or reprints contact: Mark Slifstein, PhD, New York State Psychiatric Institute, 1051 Riverside Dr., Unit 31, New York, NY 10032.
This article has been cited by other articles:
|
|
 |
|
  M. S. Milak, A. J. Severance, R. T. Ogden, J. Prabhakaran, J.S. D. Kumar, V. J. Majo, J. J. Mann, and R. V. Parsey Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET J. Nucl. Med., April 1, 2008; 49(4): 587 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Frokjaer, L. H. Pinborg, J. Madsen, R. de Nijs, C. Svarer, A. Wagner, and G. M. Knudsen Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans J. Nucl. Med., February 1, 2008; 49(2): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Buchert, F. Thiele, R. Thomasius, F. Wilke, K. Petersen, W. Brenner, J. Mester, L. Spies, and M. Clausen Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J Psychopharmacol, August 1, 2007; 21(6): 628 - 634. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Oquendo, R. S. Hastings, Y.-y. Huang, N. Simpson, R. T. Ogden, X.-z. Hu, D. Goldman, V. Arango, R. L. Van Heertum, J. J. Mann, et al. Brain Serotonin Transporter Binding in Depressed Patients With Bipolar Disorder Using Positron Emission Tomography Arch Gen Psychiatry, February 1, 2007; 64(2): 201 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Frankle, M. Slifstein, R. N. Gunn, Y. Huang, D.-R. Hwang, E. A. Darr, R. Narendran, A. Abi-Dargham, and M. Laruelle Estimation of Serotonin Transporter Parameters with 11C-DASB in Healthy Humans: Reproducibility and Comparison of Methods J. Nucl. Med., May 1, 2006; 47(5): 815 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Meyer, D. Elmenhorst, A. Matusch, O. Winz, K. Zilles, and A. Bauer 18F-CPFPX PET: On the Generation of Parametric Images and the Effect of Scan Duration J. Nucl. Med., February 1, 2006; 47(2): 200 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Boecker, T. Sprenger, G. Henriksen, T. R. Toelle, and M. E. Spilker Optimal Duration of PET Studies with 18F-Fluoroethyl-Diprenorphine J. Nucl. Med., December 1, 2005; 46(12): 2092 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Pinborg, M. Ziebell, V. G. Frokjaer, R. de Nijs, C. Svarer, S. Haugbol, S. Yndgaard, and G. M. Knudsen Quantification of 123I-PE2I Binding to Dopamine Transporter with SPECT After Bolus and Bolus/Infusion J. Nucl. Med., July 1, 2005; 46(7): 1119 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Herzog, L. Tellmann, R. Fulton, I. Stangier, E. R. Kops, K. Bente, C. Boy, R. Hurlemann, and U. Pietrzyk Motion Artifact Reduction on Parametric PET Images of Neuroreceptor Binding J. Nucl. Med., June 1, 2005; 46(6): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-D. Gallezot, M. Bottlaender, M.-C. Gregoire, D. Roumenov, J.-R. Deverre, C. Coulon, M. Ottaviani, F. Dolle, A. Syrota, and H. Valette In Vivo Imaging of Human Cerebral Nicotinic Acetylcholine Receptors with 2-18F-Fluoro-A-85380 and PET J. Nucl. Med., February 1, 2005; 46(2): 240 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Yoder, C. Wang, and E. D. Morris Change in Binding Potential as a Quantitative Index of Neurotransmitter Release Is Highly Sensitive to Relative Timing and Kinetics of the Tracer and the Endogenous Ligand J. Nucl. Med., May 1, 2004; 45(5): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-R. Hwang, R. Narendran, Y. Huang, M. Slifstein, P. S. Talbot, Y. Sudo, B. N. Van Berckel, L. S. Kegeles, D. Martinez, and M. Laruelle Quantitative Analysis of (-)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates J. Nucl. Med., February 1, 2004; 45(2): 338 - 346. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
